CJC-1295 / Ipamorelin vs BPC-157 + TB-500
CJC-1295 / Ipamorelin and BPC-157 + TB-500 come from different research areas and are studied in largely separate models — researchers usually compare them when scoping a broader protocol.
✓ both US-made · third-party tested · batch COA on every order
Last updated August 25, 2026
How do CJC-1295 / Ipamorelin and BPC-157 + TB-500 differ?
CJC-1295 / Ipamorelin (Co-formulated GHRH-analog and secretagogue blend) is catalogued under longevity & cellular research; BPC-157 + TB-500 (Co-formulated two-peptide research blend) is catalogued under recovery & gut research. Verve lists 5 reported research applications for CJC-1295 / Ipamorelin and 5 for BPC-157 + TB-500. Both are made in the United States, screened by HPLC to a 99%+ purity standard, and shipped with a batch-level certificate of analysis.
| field | CJC-1295 / Ipamorelin | BPC-157 + TB-500 |
|---|---|---|
| compound class | Co-formulated GHRH-analog and secretagogue blend | Co-formulated two-peptide research blend |
| research area | longevity & cellular | recovery & gut |
| reported research applications | 5 listed | 5 listed |
| supplied as | co-formulated blend | co-formulated blend |
| catalog sizes | 10mg | 20mg |
| purity standard | 99%+ by HPLC | 99%+ by HPLC |
| manufactured | United States | United States |
| batch COA | published per lot | published per lot |
| endotoxin-tested option | available | available |
| co-formulated together in | not co-formulated | not co-formulated |
| price from | $157.49 | $171.49 |
| availability | in stock | in stock |
Prices and stock read live from the catalog. Both compounds are supplied strictly as reference materials for in-vitro laboratory research.
What is CJC-1295 / Ipamorelin and what is BPC-157 + TB-500?
CJC-1295 / Ipamorelin is classified as Co-formulated GHRH-analog and secretagogue blend; BPC-157 + TB-500 as Co-formulated two-peptide research blend. Both profiles below cover scientific identity only — what the molecule is and which laboratory models it appears in. Verve supplies both strictly as in-vitro reference materials, and neither profile describes human or veterinary use.
CJC-1295 / Ipamorelin
Co-formulated GHRH-analog and secretagogue blend
CJC-1295 / Ipamorelin is a co-formulated research blend of two peptides that act at separate receptors. CJC-1295 without DAC, also referred to as Mod GRF 1-29, is a modified 29-amino-acid analog of growth-hormone-releasing hormone characterized as a GHRH-receptor agonist. Ipamorelin is a synthetic pentapeptide characterized as a selective agonist at the growth-hormone secretagogue receptor, GHS-R1a.
full CJC-1295 / Ipamorelin profile →BPC-157 + TB-500
Co-formulated two-peptide research blend
BPC-157 + TB-500 is a co-formulated research blend that combines two of the most frequently cited reference peptides in tissue-repair literature, BPC-157 / TB-500, in a single vial. BPC-157 is a synthetic pentadecapeptide derived from a partial sequence identified in human gastric juice; TB-500 is a synthetic 43-amino-acid peptide corresponding to an active fragment of thymosin beta-4, a naturally-occurring actin-binding protein.
full BPC-157 + TB-500 profile →Which research models is each compound studied in?
CJC-1295 / Ipamorelin sits in longevity & cellular research and BPC-157 + TB-500 in recovery & gut research, so their listed models largely do not intersect. The table lists 5 reported research applications for CJC-1295 / Ipamorelin and 5 for BPC-157 + TB-500. Rows are per compound, not equivalences.
| CJC-1295 / Ipamorelin — reported research applications | BPC-157 + TB-500 — reported research applications |
|---|---|
| Dual-pathway GHRH-receptor and GHS-R1a signaling research | Multi-compound tissue-repair research models |
| Receptor cross-talk and signal-transduction research models | Cell-migration and wound-healing research |
| Comparative agonist research versus single-component preparations | Angiogenesis and vascular-signaling research |
| Endocrine-signaling research in cellular and pre-clinical models | Actin-regulation and cytoskeletal research |
| Peptide stability and analog structure–activity research | Comparative research on blended versus single-peptide preparations |
Research contexts only. Both compounds are supplied for laboratory research use only, and no entry above describes an effect in humans or animals.
What sizes and prices does verve list for CJC-1295 / Ipamorelin and BPC-157 + TB-500?
CJC-1295 / Ipamorelin is listed from $157.49 and BPC-157 + TB-500 from $171.49. The table below is every catalog size verve currently lists for the two compounds, at single-vial prices before the automatic multi-compound discount. Sizes describe the vial format supplied to the laboratory, nothing more.
| compound | size listed | price | availability |
|---|---|---|---|
| CJC-1295 / Ipamorelin | 10mg | $157.49 | in stock |
| BPC-157 + TB-500 | 20mg | $171.49 | in stock |
Any 2 different compounds take 20% off, any 3 take 30% — applied automatically in the cart, no code. Orders placed Monday–Friday ship by 2pm CT, free over $100.
shop the compounds →Frequently asked questions about CJC-1295 / Ipamorelin and BPC-157 + TB-500
What is CJC-1295 / Ipamorelin?
It is a co-formulated research blend of CJC-1295 without DAC (also called Mod GRF 1-29), a GHRH analog, and ipamorelin, a selective GHS-R1a agonist. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
What is the difference between CJC-1295 with and without DAC?
The DAC (drug affinity complex) modification is a chemical addition studied for its effect on the analog's circulating half-life in pre-clinical models. The no-DAC form, Mod GRF 1-29, lacks that modification and is the component used in this blend.
What is BPC-157 + TB-500?
BPC-157 + TB-500 is a co-formulated research blend of two well-characterized reference peptides, BPC-157 / TB-500, supplied in one vial. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
What is the BPC-157 / TB-500 blend studied for in research?
It is used in multi-compound cellular models covering tissue repair, cell migration, angiogenesis, and actin regulation, where both peptides are studied together. Verve makes no health claims.
related comparisons
verve products are sold for laboratory research and development purposes only and are not intended for human or veterinary use of any kind. statements on this site have not been evaluated by the FDA.